| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |